BOTULINUM NEUROTOXINS TYPE A AND B

Product Description

SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
The project was carried out within Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects” based on co-financing agreement  POIG.01.04.00-14-008/13. In attachment you can find detailed description of this project.

SciencePharma

  • PL
  • 2018
    On CPHI since
  • 50 - 99
    Employees
Company types
Consultancy
Contract Research Organisation (CRO)
Contract Service
Primary activities
Chemical Development
Clinical Research
Contract Research Organisation
Medical Devices
Other
Regulatory Affairs

SciencePharma

  • PL
  • 2018
    On CPHI since
  • 50 - 99
    Employees
Company types
Consultancy
Contract Research Organisation (CRO)
Contract Service
Primary activities
Chemical Development
Clinical Research
Contract Research Organisation
Medical Devices
Other
Regulatory Affairs

More Products from SciencePharma (2)

  • CONSULTING SERVICES

    Product CONSULTING SERVICES

    SciencePharma is a leading, highly experienced consultancy company providing state-of-the-art services in a field of nonclinical and clinical studies. We gather a qualified team of experts, who carry‑out tasks from the various stages of projects/studies. As the consultancy company we deal with diversity is...
  • PHARMACOVIGILANCE

    Product PHARMACOVIGILANCE

    SciencePharma has developed full Pharmacovigilance system as described in Good Pharmacovigilance Practices (GVP) including all quality aspects and offers it to clients. We offer a comprehensive or partial services in the field of Pharmacovigilance.Our experienced, eager for knowled...

SciencePharma resources (2)

  • News BOTULINUM NEUROTOXINS TYPE A AND B

    SciencePharma, acting on behalf of its client - Nova Pharma Sp. z o.o., would like to kindly invite you to negotiate rights acquisition to the documentation of development of the method for the production and purification of botulinum neurotoxins type A and B.
    The project was carried out within Operational Programme Innovative Economy 2007-2013, Action 1.4 “Support for special projects” based on co-financing agreement  POIG.01.04.00-14-008/13. In attachment you can find detailed description of this project.
  • Brochure REGULATORY AFFAIRS SERVICES

    SciencePharma offers multidisciplinary services covering all aspects of regulatory affairs including pre-authorisation, post-authorisation as well as handling of registration process of medicinal products (human/veterinary) and medical devices across all application types and various pharmaceutical forms. We can also support you in placing dietary supplements or cosmetics on a market.